CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 9 enrolled
Drug / intervention
18F-FDGdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03590769
NCT03590769Phase 1Completed
CompareCT.gov

Arterial Imaging of Inflammation and Resolution After Endovascular Surgery

University of California, San Francisco·interventional·Posted Jul 18, 2018·Updated Nov 30, 2020

In Brief

A Phase 1 clinical trial evaluating 18F-FDG for Peripheral Arterial Disease and 6 related conditions. Completed, enrolled 9 participants across 2 sites.

Detailed Summary

This study evaluates the local inflammatory and resolution response of patients undergoing peripheral vascular intervention like an angioplasty of the superficial femoral artery (SFA) or popliteal artery, or stenting of the iliac artery or SFA, through the use of Positron emission tomography-magnetic resonance imaging (PET/MRI). PET/MRI will be performed prior to intervention, one day and one week after intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease, Claudication, Intermittent, Claudication, PAD, SFA - Superficial Femoral Artery Stenosis, Iliac Artery Disease, Vascular Calcification
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
201820192020202120222023202420252026
First PostedJul 18, 2018
Enrollment StartJun 1, 2017
Primary CompletionSep 3, 2019
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 8.0 years ago

Interventions

18F-FDGdrug

All subject will undergo PET/MRI scans pre-operatively, 1 day and 1 week post-operatively using FDG